other material
confidence high
sentiment neutral
materiality 0.60
Protagonist Therapeutics announces $100M public offering of 5M shares at $20/share
Protagonist Therapeutics, Inc
- 5,000,000 shares offered at $20.00 each; underwriters have 30-day option for 750,000 additional shares.
- Gross proceeds expected ~$100M before underwriting discounts and expenses, closing April 10, 2023.
- Underwriting syndicate led by J.P. Morgan, Jefferies, and Piper Sandler & Co.
- Shares offered under effective shelf registration statement No. 333-266595.